MTOR and Alzheimer disease: The suppression of γ-oscillations by mTOR hyperactivation, whether by Aβ1-42, leucine or in the APP/PS1 AD model, was invariably accompanied by an increase in peak frequency, which was reduced by rapamycin that restored γ power as well.